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Abstract 26 
 27 
We have recently demonstrated a strong synergy between muscarinic and 28 
adrenergic excitatory pathways in the trigone which, as part of the bladder base, 29 
plays a key role in outflow control.  This study aimed to characterise the role of 30 
intracellular Ca2+, [Ca2+]i, in this synergistic effect. Muscle strips from the superficial 31 
trigone of male guinea-pigs were used for tension experiments. In isolated muscle 32 
cells, [Ca2+]i was measured by epifluorescence microscopy using the fluorescent 33 
indicator Fura-2. Phenylephrine (PE, 10 µM) augmented contractions induced by 34 
carbachol (1 µM) to 4.0±0.8-fold of control, while corresponding [Ca2+]i levels did not 35 
exceed 1.3±0.2-fold of control. Furthermore, PE generated significantly greater 36 
contractions for a given rise of [Ca2+]i, compared to depolarising KCl solutions. The 37 
protein kinase-C inhibitor GF 109203X (5 µM) and the Rho-kinase inhibitor Y-27632 38 
(5 µM) reduced the PE contracture to 37.3±9.4 and 60.1±12.4 % of control, 39 
respectively, without significantly altering the [Ca2+]i transients. GF 109203X reduced 40 
the augmentation of 1 µM carbachol by PE to 1.5±0.1-fold of control. Muscarinic and 41 
adrenergic receptor activation exert a powerful synergistic effect in the bladder 42 
trigone without equivalent changes to the [Ca2+]i transient. Ca2+-sensitisation of 43 
contractile proteins is likely to play a key role in this synergism, particularly for 44 
adrenergic activation. 45 
 46 
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1. Introduction 50 
 51 
We recently described a strong mutual interaction between adrenergic and 52 
muscarinic contractile activation in the bladder trigone [1]. In this study, 10 µM of the 53 
alpha-1-agonist phenylephrine (PE) was effective in enhancing contractions elicited 54 
by electrical-field stimulation, as well as by exposure to other agonists. The 55 
superficial trigone develops, with the ureter, from an outgrowth of the mesonephric 56 
duct and provides, as a transverse-orientated interureteric muscle, competent vesico-57 
ureteric anchoring. Situated between the ureteric orifices and bladder outlet, it is 58 
considered to play a crucial role in uretero-vesical function, continence and 59 
micturition [2], [3]. Within the lower urinary tract, it represents an area of dual 60 
parasympathetic-muscarinic and sympathetic-adrenergic innervation. Reports about 61 
the proportion of adrenergic, muscarinic, and other transmitter systems in the trigone 62 
are variable [4], [5]. We found the muscarinic component of the electrically-evoked 63 
contraction to be about twice as significant as the adrenergic component (with a 64 
small purinergic component) [1]. However, this study demonstrated the physiological 65 
relevance of a dual receptor expression by showing a synergistic interaction. Synergy 66 
between both neurotransmitters in generating tension is of real interest because 67 
combined treatment with anti-adrenergics and anti-muscarinics for patients with both 68 
bladder outlet obstruction and overactive bladder symptoms has been shown to be 69 
highly effective not only in alleviating symptoms of urgency, but also in improving 70 
urinary outflow [6], [7], [8], [9]. The adreno-muscarinic interaction might be a result of 71 
Ca2+-sensitisation of the contractile proteins. Ca2+-sensitisation has been subject to 72 
intense research during the last few years: G-protein linked Rho-kinase (ROK) and 73 
protein kinase C (PKC) are thought to inhibit myosin phosphatase activity and 74 
therefore enhance myosin light-chain phosphorylation and cause an increase of force 75 
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[10]. Both pathways have been detected in detrusor and urethral muscle activation in 76 
different species such as human, rat, guinea-pig, and pig [11], [12]. These pathways 77 
were also found to exist in adrenoceptor-mediated contractions in trigonal smooth 78 
muscle in our preceding study [1]. 79 
The aim of this study was to reveal the role [Ca2+]i within the strong interaction 80 
between adrenergic and muscarinic pathways in the trigone and to examine the 81 
relevance of PKC and ROK in this effect. 82 
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2. Materials and Methods 83 
 84 
2.1 Tissue preparation  85 
 86 
All experiments were carried out in accordance with the UK Animals (Scientific 87 
Procedures) Act, 1986. Male guinea-pigs (400 – 500 g, Dunkin-Hartley) were killed 88 
by cervical dislocation (schedule – 1 procedure), and the bladder with adjacent 89 
urethra removed. The bladder dome was resected cranially to the ureteral entrance 90 
into the dorsal bladder base. The bladder base was then longitudinally opened on the 91 
ventral site and the trigonal area exposed. After removing the mucosa by blunt 92 
dissection, a thin strip of muscle (4-5 mm in length, average weight 6.4 mg) between 93 
the ureteral orifices was cut from the superficial part of the trigone. The superficial 94 
layer could easily be distinguished from the underlying detrusor by its paler, whitish 95 
appearance.   96 
 97 
2.2 Tension experiments  98 
 99 
Strips were tied in a horizontal superfusion trough, to a fixed hook at one end and an 100 
isometric force transducer at the other. The preparation was superfused with 101 
Tyrode´s solution at 5-10 ml.min-1 containing (mM): NaCl, 118; NaHCO3, 24.0; KCl, 102 
4.0; MgCl2, 1.0; NaH2PO4, 0.4; CaCl2, 1.8; glucose, 6.1; Na pyruvate, 5.0; pH 7.4, 103 
gassed with 95 % O2 and 5 % CO2 at 37°C; pH 7.4. Contractile responses were 104 
generated by exposure to exogenous agonists. Agonists used were carbachol (1 and 105 
10 µM) and phenylephrine (PE, 10 µM). To evaluate the effect of ROK inhibitors, 106 
tissues were incubated with (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-107 
cyclohexanecarboxamide.2HCl (Y-27632) [13] and then challenged with different 108 
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agonists. Similarly, to examine the effect of PKC inhibitors, tissues were incubated 109 
with 2-[1-(3-dimethylaminopropyl)-indol-3-yl]-3-(indol-3-yl)maleimide (GF 109203X) 110 
[14] before agonist exposure. Control experiments, using only the vehicle (DMSO) for 111 
the test agents, were always carried out and exerted no significant effects.  112 
Cell isolation. The bladder was quickly removed and placed in Ca2+-free solution 113 
containing (mM): NaCl, 105.4; NaHCO3, 20.0; KCl, 3.6; MgCl2, 0.9; NaH2PO4, 0.4; 114 
glucose, 5.5; Na pyruvate, 4.5; Hepes, 4.9; pH 7.1. The trigonal area was then 115 
dissected as described above and cells were dissociated using a collagenase-based 116 
enzyme mixture dissolved in Ca2+-free solution. Cells from the detrusor and urethral 117 
smooth muscle were similarly prepared. 118 
 119 
2.3 Measurement of intracellular calcium ([Ca2+]i) 120 
 121 
 [Ca2+]i was measured by epifluorescence microscopy using the fluorescent Ca2+ 122 
indicator Fura-2. Cells were loaded with 5 µM Fura-2 acetoxymethyl (AM) ester at 123 
37° C for 9 min and then stored at 4°C for later use. An aliquot of cell suspension 124 
was placed in a chamber mounted on the stage of an inverted microscope and 125 
superfused at 37°C with Tyrode´s solution. 0-Ca2+ superfusate contained no added 126 
CaCl2 and 0.1 mM EGTA, which buffered the ionised Ca2+ concentration to 127 
approximately pCa 8. Single cells were challenged with agonists at the same 128 
concentration as muscle strips, and to evaluate the effect of ROK- and PKC-inhibitors 129 
incubated according to the same protocol as for the intact preparation. The cells were 130 
illuminated alternately (32 Hz) at 340 and 380 nm. The emitted light was split by a 131 
dichroic mirror centred at 410 nm, and collected by a photomultiplier between 410 132 
and 510 nm. The Fura-2 ratio signal was converted to [Ca2+]i values using an in vitro 133 
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calibration method. The relationship between [Ca2+]i  and the ratio R (fluorescence 134 
ratio at 340 nm/380 nm excitation) is given by the equation [15]: 135 
   136 
[Ca2+]i  =  Kdß((R – Rmin)/(Rmax – R)), 137 
 138 
where R is the fluorescence ratio under study, Rmin and Rmax refer to ratio values at 0 139 
[Ca2+]  and saturating [Ca2+], respectively, ß is the ratio at 0 and saturating [Ca2+] at 140 
380 nm alone, and Kd (224 nM) is the dissociation constant of Fura-2 for Ca2+ . The 141 
magnitude of the [Ca2+]i rise was quantified as i) the peak deflection from the basal 142 
[Ca2+]i before an intervention; ii) the duration of the transient; or iii) the integral of the  143 
rise of the ratio tracing above the baseline. 144 
 145 
2.4 Statistics  146 
 147 
Values are given as the mean ± SD with the number of animals (n). Differences 148 
between the mean values of different sets were examined by paired or unpaired 149 
Student´s t-tests and the null hypothesis rejected at p<0.05.150 
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3. Results 151 
 152 
3.1 Trigonal cells respond exclusively to both carbachol and phenylephrine 153 
 154 
Figure 1A shows representative original traces of  [Ca2+]i in three cells, isolated from 155 
the bladder dome (A), the trigone (B), and the proximal urethra (C). All three cells 156 
were challenged with 10 µM carbachol as well as 10 µM PE. While detrusor and 157 
urethral cells would always respond respectively to either carbachol or PE alone, 158 
trigonal cells showed a clear response to both stimuli; to our knowledge, this 159 
observation has not yet been described for the trigone. Only those trigonal cells 160 
would be selected for experimentation that showed a clear response to both 161 
agonists.   162 
 163 
3.2. Ca2+- release from intracellular stores 164 
 165 
To find out whether carbachol or PE mobilise Ca2+ from intracellular stores, we 166 
superfused trigonal single cells with 0-Ca2+ solution for three minutes and then 167 
challenged the cells with 10 M PE or 10 M carbachol (Fig. 1 B). Control 168 
experiments with 40 mM KCl as well as 80 mM KCl, were always carried out prior to 169 
the agonist intervention and never showed a response in 0-Ca2+ solution. Although 170 
agonist responses were clearly reduced – probably due to loss of cytosolic Ca2+  and 171 
consequent reduction in stored Ca2+ - we still observed a [Ca2+]i  rise of 25.4 ± 19.1 % 172 
(n = 12) for PE and of 21.8 ± 22 % (n = 11) for carbachol, compared to responses in 173 
Tyrode’s solution. 174 
 175 
3.3 [Ca2+]i  elevation is insufficient to explain synergistic contractions 176 
 9
 177 
To evaluate the potentiating effect of α-adrenoreceptor (α-AR) stimulation on 178 
responses to the muscarinic agonist carbachol, intact trigonal preparations were first 179 
challenged with 1 µM carbachol for 1 min as a control response, then superfused by 180 
10 µM PE for 4 min., immediately followed by a combined intervention of 10 µM PE 181 
and 1 µM carbachol for 1 min (Fig. 2 A). The contraction evoked by carbachol in the 182 
presence of PE was measured from the new baseline of the preceding PE 183 
stimulation, representing the additional increase of force on top of the PE contraction, 184 
and compared to the response to 1 µM carbachol alone. The potentiation by PE was 185 
more than 4-fold (404.8 ± 84.6 %, n = 13, Fig. 2 C). To a similar degree, 10 µM PE 186 
increased contractions evoked by 20 mM KCl (428.1 ± 42.0 %, n = 5, Fig. 2 A and D, 187 
data from [1]). This suggests that the potentiating effect of PE takes place 188 
immediately prior to activation of the contractile machinery.  189 
 190 
To address the question whether force potentiation in the muscle preparation is 191 
directly correlated to augmented [Ca2+]i levels, we exposed isolated trigonal cells to 192 
the same protocol while recording [Ca2+]i  (Fig. 2, B). Cells displayed variable 193 
responses of [Ca2+]i  to prolonged PE exposures: constant rises for the duration of 194 
the stimulation as well as transient increases were obtained. Combined interventions 195 
were compared to the respective single control stimuli (1 µM carbachol or 20mM KCl) 196 
with respect to i) the maximum recorded [Ca2+]i rise; ii) the duration of [Ca2+]i 197 
transients; or iii) the area under the rise of [Ca2+]i traces (3) were used as variables 198 
similar results were obtained. The peak of the combined response was always 199 
measured from the new baseline when [Ca2+]i levels were still elevated at the end of 200 
PE pre-stimulation. For both KCl and carbachol experiments, a significant increase of 201 
about 30 % was recorded for the combined intervention, using the various indices of   202 
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[Ca2+]i responses as indicated above (carbachol: i) 130.3 ± 18.6 %, ii) 123.4 ± 26.0 203 
%, iii) 146.5 ± 58 %, n = 19; KCl: i) 127.2 ± 20.6, n = 15). However, there was a great 204 
discrepancy between force augmentation in muscle strips and the [Ca2+]i  rise in 205 
single cells (Fig. 2 C and D). 206 
 207 
3.4  Phenylephrine and carbachol in relation to the Ca2+/tension curve 208 
 209 
To test the hypothesis that contractile activation via the adrenergic pathway in 210 
trigonal smooth muscle employs mechanisms additional to internal Ca2+ release, we 211 
determined the position of 10 µM PE responses in relation to a Ca2+/tension curve 212 
(Fig. 3). We plotted the rise of [Ca2+]i  in single cell experiments against the amplitude 213 
of contractions in strips evoked by 10, 20, and 40 mM KCl. The point representing 214 
the 10 µM PE intervention which served as an internal reference was clearly above 215 
the plot through the KCl intervention points. This indicates that for a given rise of 216 
[Ca2+]i  evoked by adrenergic stimulation greater force is generated. 20 mM KCl 217 
elicited about the same rise in [Ca2+]i  as 10 µM PE  (94.3 ± 30.1 %, n = 12), but only  218 
25.6 ± 11.1 % (n = 10) of the contractile force. In turn, 40 mM KCl evoked a 219 
comparable contraction as 10 PE (98.3 ± 36.0 %, n = 11), but a larger rise of [Ca2+]i  220 
(169.3 ± 49.3 %, n = 22). The 1 M carbachol intervention point lies close to the KCl 221 
Ca2+/tension curve, showing that in trigonal muscle muscarinic force activation is 222 
predominantly determined by Ca2+ rise.  223 
 224 
3.5 The effect of PKC and ROK inhibition on the response to phenylephrine 225 
Ca2+ sensitisation by ROK and PKC has recently been shown to play a role in 226 
detrusor activation [13]. We investigated the effect of the ROK inhibitor Y-27632 227 
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(5 µM) and PKC inhibitor GF 109203X (5 µM) on contractions and [Ca2+]i levels in the 228 
trigone when evoked by PE (Fig. 4 A, B). Pre-incubation with GF 109203X (30 min) 229 
caused a reduction of the PE contracture to 37.3 ± 9.4 % of control (n = 14). 230 
Contractile force completely recovered after 15 – 30 min. A longer incubation did not 231 
reduce the contracture any further and did not prevent full recovery. With single cells, 232 
levels of [Ca2+]i were not affected by GF 109203 X (103.7 ± 5.6 %, n = 6). Y-27632 233 
reduced the PE contraction to a lesser extent (60.1 ± 12.4 % of control, n = 8) without 234 
significant alteration of [Ca2+]i  (101.2 ± 29.4 %, n = 6). 235 
 236 
3.6 The effect of PKC and ROK inhibition on the potentiated muscarinic component 237 
 238 
To explore further the hypothesis that the synergy described above between 239 
adrenergic and muscarinic activation is due to kinase activity, we incubated muscle 240 
strips with the PKC or ROK inhibitor for 30 min. The preparation was then superfused 241 
with 10 M PE alone, followed by the combined intervention (10 M PE + 1 M 242 
carbachol), and the enhanced muscarinic component compared to that from 1 M 243 
carbachol alone (Fig. 4 C). Similar results were obtained when the sequence of the 244 
interventions was changed. There was still a significant, but greatly reduced increase 245 
of force (145.7 ± 14.5 %, n = 5, vs. 404.8 ± 84.6 % of control) after PKC inhibition. 246 
Incubation with the ROK inhibitor, in turn, reduced the potentiating effect by a 247 
smaller, but still significantly different, degree (295.8 ± 34.24 %, n = 4, of control). 248 
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4. Discussion 249 
 250 
4.1 Cellular synergism is mediated through calcium sensitisation 251 
 252 
In contrast to previously reported facilitation of acetylcholine release by prejunctional 253 
-ARs in the detrusor [16], the force-potentiating interaction between adrenergic and 254 
muscarinic neurotransmission in the trigone is a true synergistic effect on the muscle  255 
cells themselves. In this study, we measured changes to [Ca2+]i in parallel 256 
experiments to tension recording. It is important to note that the same cell responded 257 
to both muscarinic and adrenergic stimulation, discounting the possibility that the 258 
dual innervation of the trigone might be a mere result of two distinct cell populations. 259 
The strong synergistic effect seen when recording tension with intact muscle 260 
preparations was not mirrored by changes to [Ca2+]i , although a significant [Ca2+]i 261 
increase to carbachol of about 30 % was recorded with 10 M PE. Even assuming 262 
that preactivation by PE caused a shift to the steep part of the Ca2+/tension curve, 263 
where a similar rise of [Ca2+]i  would result in a larger contraction,  an increase of not 264 
more than 30 % in [Ca2+]i  could not  explain the more than 4-fold potentiation of 265 
tension. 266 
 267 
The hypothesis that the adrenergic pathway must involve mechanisms additional to 268 
IP3-mediated Ca2+-release from intracellular stores, was supported by the finding that 269 
PE required lower [Ca2+]i  levels than high-KCl solutions to generate the same 270 
contractile force. When [Ca2+]i is constant, agonists activating G-protein-coupled 271 
receptors might cause a leftward shift of the Ca2+/tension curve, i.e. Ca2+-272 
sensitisation. The two major G-protein-coupled pathways operate through PKC and  273 
ROK. It was therefore of interest to determine if the adrenergic pathway in trigonal 274 
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muscle activation involves Ca2+-sensitisation, and by which route. We found the 275 
contraction to phenylephrine to be dramatically reduced by the PKC-inhibitor GF 276 
109203X and, to a smaller extent, by the ROK-inhibitor Y-27632, while levels of 277 
intracellular Ca2+ changes were similar. The effect of PKC- and ROK-inhibition on the 278 
augmented muscarinic response in the combined intervention clearly shows that both 279 
PKC and ROK mediate synergism in contraction. In previous experiments [1], PKC 280 
as well as ROK inhibition were without significant effect on the contracture evoked by 281 
carbachol alone, whereas in the combined intervention, the enhanced muscarinic 282 
component was reduced by 73 % and 36 %, respectively. 283 
 284 
4.2 Source of   [Ca2+]i   285 
 286 
The observation that under -AR stimulation, cell depolarisation by KCl elicits a 30% 287 
higher [Ca2+]i  rise, suggests also a modulation of voltage-dependent Ca2+ channels  - 288 
an effect which has been established in cardiac myocytes and employs PKC to 289 
phosphorylate L-type Ca2+-channels [21]. To the same degree, -AR activation was 290 
shown to facilitate carbachol-induced Ca2+-release from intracellular stores. However, 291 
this interaction may not be mediated by PKC, as PKC inhibition had no effect on 292 
[Ca2+]i  transients elicited by PE itself, which – like carbachol – activates IP3 and 293 
mobilises Ca2+ from intracellular stores. This is in accordance with previous reports 294 
where inhibition of PKC or ROK had no effect on carbachol-evoked [Ca2+]i  transients 295 
in the detrusor [12]. We have not characterised in detail the nature of the intracellular 296 
Ca2+-stores and messengers in this study – this is subject of current investigations. 297 
 298 
However, [Ca2+]i  contributes to some extent to the synergistic interaction between 299 
adrenergic and muscarinic pathways in the bladder trigone, and might (together with 300 
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still active ROK) be responsible for the 40 % force augmentation of the combined 301 
intervention still seen under PKC inhibition. 302 
 303 
Interpretation of the reduced carbachol-response following L-type Ca2+ channel 304 
knock-out in a recent study initiated a debate as to whether agonist stimulation of 305 
bladder smooth muscle opens membrane Ca2+-channels or release Ca2+ from 306 
intracellular stores [18]. Our data suggest that agonist stimulation of trigonal smooth 307 
muscle involves Ca2+ release from intracellular stores, evidenced by the persistence 308 
of PE and carbachol-induced [Ca2+] rise in Ca2+-free solution when KCl-induced Ca2+ 309 
entry was abolished. A Ca2+-free environment inevitably causes continuous loss of 310 
cytosolic Ca2+ and depletion of intracellular stores, which explains the reduction of 311 
resting [Ca2+]i and the decrease in [Ca2+]i response to agonists; however, significant 312 
responses to PE and carbachol were measured, in contrast to KCl interventions. 313 
 314 
4.3  Clinical implications  315 
 316 
Our data suggest a strong interaction between muscarinic and adrenergic pathways 317 
in the bladder trigone: the muscarinic pathway predominantly operates through 318 
modulation of [Ca2+]i; the adrenergic pathway significantly alters the Ca2+-sensitivity 319 
of the contractile machinery. The latter provides an effective mechanism to allow the 320 
bladder neck to switch between a closed to open state, especially in combination with 321 
an NO-based relaxation process [3].  322 
 323 
Recent reports suggest the advantages of a combined anti-muscarinic and anti-324 
adrenergic therapy  in patients suffering from both bladder outflow obstruction and 325 
overactive bladder symptoms; only the combined use of the muscarinic antagonist 326 
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tolterodine and the alpha-adrenergic antagonist tamsulosin has been shown to be 327 
effective with respect to both parameters quality of life and maximum urine flow rate 328 
[6], [7], [8], [9]. This is the first experimental study providing an explanation for the 329 
beneficial effect of a simultaneous muscarinic and adrenergic blockade in the trigone 330 
as the dorsal part or the bladder base. It might well be that in conditions of 331 
simultaneous mechanical obstruction and increased muscarinic tone, the inhibition of 332 
both synergistic components – adrenergic-driven Ca2+-sensitisation and muscarinic-333 
driven [Ca2+]i increase –  achieves the highest possible reduction of outflow 334 
resistance in the bladder base and neck. 335 
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5. Conclusion 336 
This study demonstrates that the adrenergic pathway in the bladder trigone mainly 337 
operates through Ca2+-sensitisation and is thereby capable of a more than  4-fold 338 
potentiation of muscarinic force activation. It supports recent reports about the high 339 
effectiveness of a combined anti-muscarinic and anti-adrenergic therapy in patients 340 
with both OAB and outflow obstruction. 341 
 342 
 343 
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Figure legends 404 
 405 
Figure 1 406 
A: [Ca2+]i recordings of myocytes isolated from the bladder dome (D, top), the trigone 407 
(T, middle), and the proximal urethra (U, bottom), challenged with 10 µM carbachol 408 
and the α1-adrenergic agonist phenylephrine (PE, 10 µM). The diagram (left) shows 409 
the approximate sites from where the cells were obtained. B: Effect of 0-Ca2+ solution 410 
on [Ca2+]i transients elicited by 10 µM PE (top), 10 µM carbachol (middle) and 40 mM 411 
KCl (bottom). Traces in part A (middle) and B were all from one cell preparation. 412 
 413 
Figure 2 414 
Representative traces showing contractures of intact trigone strips (A) and [Ca2+]i 415 
transients (B) in isolated trigonal cells. Responses were elicited by 1 µM carbachol or 416 
20 mM KCl alone or in the presence of 10 µM PE.  Summary of the effects of 1 µM 417 
carbachol (C) or 20 mM KCl (D) on tension and [Ca2+]i in the absence and presence 418 
of 10 µM PE, mean ± sd; * p<0.05; † data from [1]. 419 
 420 
Figure 3 421 
The relationship between isometric contracture tension and the increase of [Ca2+]i by 422 
10, 20, and 40 mM KCl solutions (closed circles), and 1 µM carbachol (open square). 423 
Data are expressed as a proportion of these variables elicited by 10 µM PE (large 424 
closed square). The curve was fitted by a least-squares method (KaleidaGraphTM, 425 
Synergy Software). 426 
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Figure 4 427 
A: The effect of the protein kinase-C inhibitor GF 109203 X (5 µM) on 10 µM PE 428 
contractures (top) and [Ca2+]i (bottom). Tension and [Ca2+]i records were obtained 429 
from different preparations. B: Force and [Ca2+]i elicited by 10 µM PE after incubation 430 
with GF 109203 X and Rho-kinase inhibitor Y-27632 (5 µM). Data are shown as a 431 
percentage of the values in the absence of these inhibitors. C: The effect of GF 432 
109203 X and Y-27632 on the augmentation of the 1 µM carbachol contracture by 10 433 
µM PE; format as in part B; * p<0.05 compared to control; † p<0.05 compared to 434 
carbachol + PE without pre-incubation. 435 
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